Update on irritable bowel syndrome program of research

Journal of Korean Academy of Nursing

Volumn 43, Issue 5, 2013, Pages 579-586

  Heitkemper, Margaret ^a   Jarrett, Monica ^a   Jun, Sang Eun ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Keimyung University   (South Korea)

Author keywords

Adults; Diagnosis; Etiology; Irritable bowel syndrome; Treatment

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULTS; ARTICLE; CLINICAL NURSING RESEARCH; DIAGNOSIS; ETIOLOGY; FEMALE; HUMAN; IRRITABLE COLON; PATHOPHYSIOLOGY; SELF CARE; TREATMENT;

ADULTS; DIAGNOSIS; ETIOLOGY; IRRITABLE BOWEL SYNDROME; TREATMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL NURSING RESEARCH; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IRRITABLE BOWEL SYNDROME; SELF CARE;

EID: 84890722739     PISSN: 20053673     EISSN: 20937482     Source Type: Journal    
DOI: 10.4040/jkan.2013.43.5.579     Document Type: Article

References (67)

1. Aguilera, M., Vergara, P., & Martínez, V. (2013). Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice. Neurogastroenterology and Motility, 25(8), e515-e529. http://dx.doi.org/10.1111/nmo.12154
2. Alonso, C., Guilarte, M., Vicario, M., Ramos, L., Ramadan, Z., Antolin, M., et al. (2008). Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation. Gastroenterology, 135(1), 163-172, e161. http://dx.doi.org/10.1053/j.gastro.20 08.03.036
3. Amaral, F. A., Sachs, D., Costa, V. V., Fagundes, C. T., Cisalpino, D., Cunha, T. M., et al. (2008). Commensal microbiota is fundamental for the development of inflammatory pain. Proceedings of the National Academy of Sciences of the United States of America, 105(6), 2193-2197. http:// dx.doi.org/10.1073/pnas.0711891105
4. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt, L.J., Chey, W.D., Foxx-Orenstein, A.E., Schiller, L.R., Schoenfeld, P.S., et al. (2009). An evidence-based position statement on the management of irritable bowel syndrome. The American Journal of Gastroenterology, 104 (Suppl 1), S1-S35. http://dx.doi.org/10.1038/ajg. 2008.122
5. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., et al. (2011). Enterotypes of the human gut microbiome. Nature, 473(7346), 174-180. http://dx.doi.org/10.1038/nature09944
6. Bellini, M., Gemignani, A., Gambaccini, D., Toti, S., Menicucci, D., Stasi, C., et al. (2011). Evaluation of latent links between irritable bowel syndrome and sleep quality. World Journal of Gastroenterology, 17(46), 5089-5096. http://dx.doi.org/10.3748/wjg.v17.i46.5089
7. Bercik, P., Park, A. J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., et al. (2011). The anxiolytic effect of bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterology and Motility, 23(12), 1132-1139. http://dx.doi.org/10.1111/j.1365-29 82.2011.01796.x
8. Bradford, K., Shih, W., Videlock, E. J., Presson, A. P., Naliboff, B. D., Mayer, E. A., et al. (2012). Association between early adverse life events and irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 10(4), 385-390, e381-e383. http://dx.doi.org/10.1016/j.cgh.2011.12.018
9. Cain, K. C., Headstrom, P., Jarrett, M. E., Motzer, S. A., Park, H., Burr, R. L., et al. (2006). Abdominal pain impacts quality of life in women with irritable bowel syndrome. The American Journal of Gastroenterology, 101(1), 124-132. http://dx.doi.org/10.1111/j.1572-0241.2006.00404.x
10. Cain, K. C., Jarrett, M. E., Burr, R. L., Hertig, V. L., & Heitkemper, M. M. (2007). Heart rate variability is related to pain severity and predominant bowel pattern in women with irritable bowel syndrome. Neurogastroenterology and Motility, 19(2), 110-118. http://dx.doi.org/10.1111 / j.1365-2982.2006.00877.x
11. Camilleri, M., & Katzka, D. A. (2012). Irritable bowel syndrome: Methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. American Journal of Physiology: Gastrointestinal and Liver Physiology, 302(10), G1075-G1084. http://dx.doi.org/10.1152/ajpgi.00537.2011
12. Camilleri, M., Lasch, K., & Zhou, W. (2012). Irritable bowel syndrome: Methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. American Journal of Physiology: Gastrointestinal and Liver Physiology, 303(7), G775-G785. http://dx.doi.org/10.1152/ajpgi.00155.2012
13. Camilleri, M., McKinzie, S., Busciglio, I., Low, P. A., Sweetser, S., Burton, D., et al. (2008). Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 6(7), 772-781. http://dx.doi.org/10.10 16/j.cgh.2008.02.060
14. Camilleri, M., & Talley, N. J. (2004). Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterology and Motility, 16(2), 135-142. http://dx.doi.org/10.1111/j.13 65-2982.2004.00516.x
15. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes, 57(6), 1470-1481. http://dx.doi.org/10.2337 /db07-1403
16. Chang, L., Adeyemo, M., Karagiannides, I., Videlock, E. J., Bowe, C., Shih, W., et al. (2012). Serum and colonic mucosal immune markers in irritable bowel syndrome. The American Journal of Gastroenterology, 107(2), 262-272. http://dx.doi.org/10.1038/ajg.2011.423
17. Chitkara, D. K., van Tilburg, M. A., Blois-Martin, N., & Whitehead, W. E. (2008). Early life risk factors that contribute to irritable bowel syndrome in adults: A systematic review. The American Journal of Gastroenterology, 103(3), 765-774, quiz 775. http://dx.doi.org/10.1111/j.15 72-0241.2007.01722.x
18. Coëffier, M., Gloro, R., Boukhettala, N., Aziz, M., Lecleire, S., Vandaele, N., et al. (2010). Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. The American Journal of Gastroenterology, 105(5), 1181-1188. http://dx.doi.org/10.1038/ajg.2009.700
19. Cremon, C., Gargano, L., Morselli-Labate, A. M., Santini, D., Cogliandro, R. F., De Giorgio, R., et al. (2009). Mucosal immune activation in irritable bowel syndrome: Gender-dependence and association with digestive symptoms. The American Journal of Gastroenterology, 104(2), 392-400. http://dx.doi.org/10.1038/ajg.2008.94
20. Dinan, T. G., & Cryan, J. F. (2012). Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinology. Psychoneuroendocrinology, 37(9), 1369-1378. http://dx.doi.org/10.1016/ j.psyneuen.2012.03.007
21. Drossman, D. A., Corazziari, E., Delvaux, M., Spiller, R. C., Talley, N. J., Thompson, W. G., et al. (Eds.). (2006). Rome III: The functional gastrointestinal disorders (3rd ed.). McLean, VA: Degnon Associates.
22. Elsenbruch, S., Thompson, J. J., Hamish, M. J., Exton, M. S., & Orr, W. C. (2002). Behavioral and physiological sleep characteristics in women with irritable bowel syndrome. The American Journal of Gastroenterology, 97(9), 2306-2314. http://dx.doi.org/10.1111/j.1572-0241.2002. 05984.x
23. Eutamene, H., Lamine, F., Chabo, C., Theodorou, V., Rochat, F., Bergonzelli, G. E., et al. (2007). Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. The Journal of Nutrition, 137(8), 1901-1907.
24. Foster, J. A., & McVey Neufeld, K. A. (2013). Gut-brain axis: How the microbiome influences anxiety and depression. Trends in Neurosciences, 36(5), 305-312. http://dx.doi.org/10.1016/j.tins.2013.01.005
25. Goo, Y. A., Cain, K., Jarrett, M., Smith, L., Voss, J., Tolentino, E., et al. (2012). Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups. Journal of Proteome Research, 11(12), 5650-5662. http:// dx.doi.org/10.1021/pr3004437
26. Gwee, K. A., & Ghoshal, U. C. (2010). The Rome criteria divides, distorts and dilutes the prevalence of irritable bowel syndrome. Saudi Journal of Gastroenterology, 16(3), 143-144. http://dx.doi.org/10.4103/1319-3767. 65178
27. Halpert, A. D. (2010). Importance of early diagnosis in patients with irritable bowel syndrome. Postgraduate Medicine, 122(2), 102-111. http:// dx.doi.org/10.3810/pgm.2010.03.2127
28. Heitkemper, M., Jarrett, M., Burr, R., Cain, K. C., Landis, C., Lentz, M., et al. (2005). Subjective and objective sleep indices in women with irritable bowel syndrome. Neurogastroenterology and Motility, 17(4), 523-530. http://dx.doi.org/10.1111/j.1365-2982.2005.00700.x
29. Heitkemper, M. M., Cain, K. C., Deechakawan, W., Poppe, A., Jun, S. E., Burr, R. L., et al. (2012). Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome. Neurogastroenterology and Motility, 24(7), 626-631, e270-e271. http://dx.doi.org/10.1111/j.1365-2982.2012.01915.x
30. Heitkemper, M. M., Jarrett, M. E., Levy, R. L., Cain, K. C., Burr, R. L., Feld, A., et al. (2004). Self-management for women with irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 2(7), 585-596.
31. Heitkemper, M. M., Kohen, R., Jun, S. E., & Jarrett, M. E. (2011). Genetics and gastrointestinal symptoms. Annual Review of Nursing Research, 29, 261-280.
32. Hsueh, H. F., Jarrett, M. E., Cain, K. C., Burr, R. L., Deechakawan, W., & Heitkemper, M. M. (2011). Does a self-management program change dietary intake in adults with irritable bowel syndrome? Gastroenterology Nursing, 34(2), 108-116. http://dx.doi.org/10.1097/SGA.0b013e31 821092e8
33. Hughes, P. A., Zola, H., Penttila, I. A., Blackshaw, L. A., Andrews, J. M., & Krumbiegel, D. (2013). Immune activation in irritable bowel syndrome: Can neuroimmune interactions explain symptoms? The American Journal of Gastroenterology, 108(7), 1066-1074. http://dx.doi. org/10.1038/ajg.2013.120
34. Hyams, J. S., Hyman, P. E., & Rasquin-Weber, A. (1999). Childhood recurrent abdominal pain and subsequent adult irritable bowel syndrome. Journal of Developmental and Behavioral Pediatrics, 20(5), 318-319.
35. Inadomi, J. M., Fennerty, M. B., & Bjorkman, D. (2003). Systematic review: The economic impact of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 18(7), 671-682.
36. Jarrett, M. E., Cain, K. C., Burr, R. L., Hertig, V. L., Rosen, S. N., & Heitkemper, M. M. (2009). Comprehensive self-management for irritable bowel syndrome: Randomized trial of in-person vs. combined in-person and telephone sessions. The American Journal of Gastroenterology, 104(12), 3004-3014. http://dx.doi.org/10.1038/ajg.2009.479
37. Jarrett, M. E., Kohen, R., Cain, K. C., Burr, R. L., Poppe, A., Navaja, G. P., et al. (2007). Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biological Research for Nursing, 9(2), 161-169. http://dx.doi.org/10.1177/1099800407307822
38. Jarrett, M., Heitkemper, M., Cain, K. C., Burr, R. L., & Hertig, V. (2000). Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Digestive Diseases and Sciences, 45(5), 952-959.
39. Jarrett, M., Visser, R., & Heitkemper, M. (2001). Diet triggers symptoms in women with irritable bowel syndrome. The patient's perspective. Gastroenterology Nursing, 24(5), 246-252.
40. Jeffery, I. B., O'Toole, P. W., Öhman, L., Claesson, M. J., Deane, J., Quigley, E. M., et al. (2012). An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut, 61(7), 997-1006. http://dx.doi.org/10.1136/gutjnl-2011-301501
41. Jeffery, I. B., Quigley, E. M., Öhman, L., Simrén, M., & O'Toole, P. W. (2012). The microbiota link to irritable bowel syndrome: An emerging story. Gut Microbes, 3(6), 572-576. http://dx.doi.org/10.4161/gmic.21772
42. Jun, S., Kohen, R., Cain, K. C., Jarrett, M. E., & Heitkemper, M. M. (2011). Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome. Neurogastroenterology and Motility, 23(3), 233-239, e116. http://dx.doi.org/10.1111/j.1365-2982.2010.01623.x
43. Jung, H. K., Jang, B., Kim, Y. H., Park, J., Park, S. Y., Nam, M. H., et al. (2011). Health care costs of digestive diseases in Korea. The Korean Journal of Gastroenterology, 58(6), 323-331.
44. Konturek, P. C., Brzozowski, T., & Konturek, S. J. (2011). Stress and the gut: Pathophysiology, clinical consequences, diagnostic approach and treatment options. Journal of Physiology and Pharmacology, 62(6), 591-599.
45. Kumar, S., Ranjan, P., Mittal, B., & Ghoshal, U. C. (2012). Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls. Journal of Gastrointestinal and Liver Diseases, 21(1), 31-38.
46. Lackner, J. M., Gudleski, G. D., Zack, M. M., Katz, L. A., Powell, C., Krasner, S., et al. (2006). Measuring health-related quality of life in patients with irritable bowel syndrome: Can less be more? Psychosomatic Medicine, 68(2), 312-320. http://dx.doi.org/10.1097/01.psy.0000204897.25745.7c
47. Lackner, J. M., Mesmer, C., Morley, S., Dowzer, C., & Hamilton, S. (2004). Psychological treatments for irritable bowel syndrome: A systematic review and meta-analysis. Journal of Consulting and Clinical Psychology, 72(6), 1100-1113.
48. Larsen, N., Vogensen, F. K., van den Berg, F. W., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., et al. (2010). Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 5(2), e9085. http://dx.doi.org/10.1371/journal.pone.0009085
49. Ledochowski, M., Widner, B., Bair, H., Probst, T., & Fuchs, D. (2000). Fructose-and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scandinavian Journal of Gastroenterology, 35(10), 1048-1052.
50. Ljótsson, B., Hedman, E., Andersson, E., Hesser, H., Lindfors, P., Hursti, T., et al. (2011). Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: A randomized trial. The American Journal of Gastroenterology, 106(8), 1481-1491. http://dx.doi. org/10.1038/ajg.2011.139
51. Marshall, J. K., Thabane, M., Garg, A. X., Clark, W., Meddings, J., & Collins, S. M. (2004). Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Alimentary Pharmacology and Therapeutics, 20(11-12), 1317-1322. http://dx.doi.org/10.1111/j.1365-2036.2004.02284.x
52. McKenzie, Y. A., Alder, A., Anderson, W., Wills, A., Goddard, L., Gulia, P., et al. (2012). British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. Journal of Humam Nutrition and Dietetics, 25(3), 260-274. http://dx.doi.org/ 10.1111/j.1365-277X.2012.01242.x
53. Messaoudi, M., Violle, N., Bisson, J. F., Desor, D., Javelot, H., & Rougeot, C. (2011). Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes, 2(4), 256-261. http://dx. doi.org/10.4161/gmic.2.4.16108
54. Moayyedi, P., & Ford, A. C. (2011). Symptom-based diagnostic criteria for irritable bowel syndrome: The more things change, the more they stay the same. Gastroenterology Clinics of North America, 40(1), 87-103. http://dx.doi.org/10.1016/j.gtc.2010.12.007
55. Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., et al. (2010). The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut, 59(3), 325-332. http://dx.doi.org/10.1136/gut.2008.167270
56. Neufeld, K. M., Kang, N., Bienenstock, J., & Foster, J. A. (2011). Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterology and Motility, 23(3), 255-264, e119. http:// dx.doi.org/10.1111/j.1365-2982.2010.01620.x
57. Nojkov, B., Rubenstein, J. H., Chey, W. D., & Hoogerwerf, W. A. (2010). The impact of rotating shift work on the prevalence of irritable bowel syndrome in nurses. The American Journal of Gastroenterology, 105(4), 842-847. http://dx.doi.org/10.1038/ajg.2010.48
58. Park, D. W., Lee, O. Y., Shim, S. G., Jun, D. W., Lee, K. N., Kim, H. Y., et al. (2010). The differences in prevalence and sociodemographic characteristics of irritable bowel syndrome according to Rome II and Rome III. Journal of Neurogastroenterology and Motility, 16(2), 186-193. http:// dx.doi.org/10.5056/jnm.2010.16.2.186
59. Rajilic-Stojanovic, M., Biagi, E., Heilig, H. G., Kajander, K., Kekkonen, R. A., Tims, S., et al. (2011). Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology, 141(5), 1792-1801. http://dx.doi.org/10. 1053/ j.gastro.2011.07.043
60. Robert, J. J., Orr, W. C., & Elsenbruch, S. (2004). Modulation of sleep quality and autonomic functioning by symptoms of depression in women with irritable bowel syndrome. Digestive Diseases and Sciences, 49(7-8), 1250-1258.
61. Rodríguez-Fandiño, O., Hernández-Ruiz, J., & Schmulson, M. (2010). From cytokines to toll-like receptors and beyond-current knowledge and future research needs in irritable bowel syndrome. Journal of Neurogastroenterology and Motility, 16(4), 363-373. http://dx.doi.org/10.50 56/jnm.2010.16.4.363
62. Rotem, A. Y., Sperber, A. D., Krugliak, P., Freidman, B., Tal, A., & Tarasiuk, A. (2003). Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep, 26(6), 747-752.
63. Saulnier, D. M., Riehle, K., Mistretta, T. A., Diaz, M. A., Mandal, D., Raza, S., et al. (2011). Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology, 141(5), 1782-1791. http://dx.doi.org/10.1053/j.gastro.2011.06.072
64. Schmulson, M., Pulido-London, D., Rodriguez, O., Morales-Rochlin, N., Martinez-García, R., Gutierrez-Ruiz, M. C., et al. (2012). Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico. The American Journal of Gastroenterology, 107(5), 747-753. http://dx. doi.org/10.1038/ajg.2011.484
65. Shulman, R. J., Eakin, M. N., Czyzewski, D. I., Jarrett, M., & Ou, C. N. (2008). Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. The Journal of Pediatrics, 153(5), 646-650. http://dx.doi.org/10. 1016/j.jpeds.2008.04.062
66. Walther, D. J., & Bader, M. (2003). A unique central tryptophan hydroxylase isoform. Biochemical Pharmacology, 66(9), 1673-1680.
67. Zill, P., Büttner, A., Eisenmenger, W., Möller, H. J., Ackenheil, M., & Bondy, B. (2007). Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: A post-mortem study. Journal of Psychiatric Research, 41(1-2), 168-173. http://dx.doi.org/10.1016/j.jpsychires.2005. 05.004